Tag: cancer
-
Virtual Pathology Image Company Opens, Raises $15.2M
A developer of virtual tissue staining systems aided by algorithms for medical images began public operations today, raising $15.2 million in venture funds.
-
Biotech, Regeneron in $2B Cancer Antibody Deal
A developer of cancer treatments triggered by tumor chemistry is partnering with biologic drug maker Regeneron on dual-action cancer immunotherapies.
-
Residual Cancer Detection Company Launches, Raises $56M
A start-up enterprise developing personalized liquid biopsies for finding residual cancer in patients is beginning work and raising $56 million in venture funds.
-
Biotech, M.D. Anderson Partner on Precision Drug Design
A company discovering therapies with artificial intelligence is partnering with M.D. Anderson Cancer Center on new small-molecule precision medicines.
-
Patent Awarded for Focused Ultrasound Skin Treatments
A company developing non-invasive ultrasound treatments for treating skin disorders and removing tattoos received a patent for its technology.
-
Trial Shows Results for Personal Cancer Immunotherapies
Interim results from a clinical trial testing personalized therapies invoking the immune system show responses from some patients with advanced liver cancer.
-
Cancer Detection Start-Up Gains $4M in Seed Funds
A developer of early-stage non-invasive cancer detection tests based on research in university labs is raising $4 million in its seed venture round.
-
AI Analytics Boost Breast Cancer Assessment Diversity
A genomic analytics company says an ethnicity algorithm added to a personal health questionnaire improves risk assessments for breast cancer across all populations.
-
Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors
Research with lab animals shows an experimental cancer vaccine generates immune-system cells that infiltrate solid tumors and reduce the tumor’s protective environment.
-
Immunotherapy Start-Up Launches Collaboration, Raises $65M
A new biotechnology company is creating cancer immunotherapies that it says harness more of the full power of T-cells in the immune system to attack tumors.